Press Releases

12345678910
Coya Therapeutics Announces Completion of Full Enrollment in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, today announced full enrollment of the planned 120 participants in the Company’s Phase 2/3 ALSTARS Trial (NCT07161999) evaluating COYA 302, Coya’s combination of proprietary low-dose IL-2 and CTLA-4 Ig, for the potential treatment of amyotrophic lateral sclerosis (ALS). Additional participants already engaged in active screening will be allowed to enroll in the trial if deemed eligible. Topline data from the double-blind treatment phase are anticipated in early Q2 2027.
By Coya Therapeutics, Inc. · Via Business Wire · October 5, 2026
Emil Ben-David, CFP®, Joins Prime Capital Financial
Prime Capital Financial today announced that Emil Ben-David, CFP®, has joined the firm as a wealth advisor.
By Prime Capital Financial · Via Business Wire · October 5, 2026
HOPE Global Forums Announces 2026 Annual Meeting on December 2-3 in Atlanta
The Annual Meeting of the HOPE Global Forums, the world’s largest gathering dedicated to economic inclusion, financial literacy and the empowerment of underserved communities, will take place December 2-3, 2026 at the Signia by Hilton in downtown, marking the 12th year that Operation HOPE’s flagship global gathering will be held in Atlanta.
By Operation HOPE · Via Business Wire · October 5, 2026
Fasikl’s Felix Wristband Improves Daily and Long-Term Function for People with Essential Tremor with Ongoing Use, New One-Year Data Show
Fasikl, a trailblazing neuro-AI company redefining the intersection of advanced bioelectronic medicine and artificial intelligence (AI), today announced that patients with essential tremor (ET) who used the Felix NeuroAI™ Wristband saw clinically meaningful and sustained functional improvement over a full year, with greater improvement the longer they used it, according to new peer-reviewed data published in Movement Disorder Clinical Practice.1 Another recent article in the same publication established clinically meaningful change thresholds for two commonly used Essential Tremor Rating Assessment Scale (TETRAS)-based outcome measures in ET.2
By Fasikl · Via Business Wire · October 5, 2026
o9 Named a Leader in the IDC MarketScape: Worldwide Retail Merchandise Financial Planning Solutions 2026 Vendor Assessment
o9 Solutions, a leading software company that is powering enterprise planning and decisioning models across 30-plus industry verticals with its groundbreaking, AI-powered Digital Brain platform, today announced that it has been named a Leader in the IDC MarketScape: Worldwide Retail Merchandise Financial Planning Solutions 2026 Vendor Assessment (Doc #US54125926, September 2026).
By o9 Solutions · Via Business Wire · October 5, 2026
McGraw Hill to Release Fiscal Second Quarter 2027 Financial Results and Host Webcast on November 5, 2026
McGraw Hill, Inc. (NYSE: MH; “McGraw Hill” or the “Company”), a leading global provider of education solutions for preK-12, higher education and professional learning, will report fiscal second quarter financial results for the period ended September 30, 2026 on Thursday, November 5, 2026.
By McGraw Hill · Via Business Wire · October 5, 2026
Lumentum Announces Reporting Date for Fiscal First Quarter 2027 Financial Results
Lumentum Holdings Inc. ("Lumentum") today announced that it will release its fiscal first quarter 2027 financial results on Thursday, November 5th, 2026, after the market closes.
By Lumentum · Via Business Wire · October 5, 2026
SFNet Announces FY27 Leadership Appointments
The Secured Finance Network (SFNet) Member Directors have elected the FY27 SFNet Management Committee and Executive Committee members, with approval from the Executive Committee. The Secured Finance Foundation (SFFound) Member Donors have also elected the FY27 SFFound Board and Officers, with approval from the SFFound Board.
By Secured Finance Network · Via Business Wire · October 5, 2026
Gallup and The Rippel Foundation Report Finds U.S. Well-Being Rates Near Historic Lows, But Local Communities Are Charting A Path Forward
Gallup and The Rippel Foundation today released Thriving Together in America: Trends, Discoveries, Community Action, and Advice for Leaders, a new report that draws on Gallup's national well-being data with insights from community practitioners working to reverse the decline. The research finds that American well-being has fallen to near historic lows, while hope — Americans’ confidence that their future will be better — has reached its lowest point since Gallup began tracking it in 2008. The report also finds this decline is not inevitable: communities across the country are already using well-being data to understand local conditions, bring residents and leaders together around shared challenges, and change the trajectory.
By The Rippel Foundation · Via Business Wire · October 5, 2026
BioCentury Grand Rounds Heads to Houston, Texas, for Its Sixth Meeting Designed to Connect Early-Stage Science with Today’s Investors and Executives
BioCentury is pleased to announce that registration is now open for the sixth edition of BioCentury Grand Rounds, taking place April 12–14, 2027, in Houston, Texas. The conference convenes academic innovators, biotech founders, biopharma leaders, and investors to bridge the gap between early-stage science and breakthrough new medicines. Registration, scientific poster nominations, and Presenting Company applications are now open.
By BioCentury · Via Business Wire · October 5, 2026
I2Pure Expands Leadership and Scientific Team with Three Key Hires in Production, Quality Engineering, and Biomaterials Science
I2Pure Corp., a biotechnology company specializing in patented molecular iodine (I₂) technology for antimicrobial and antiseptic applications, today announced three recent additions to its team. Based in the company’s Asheville, NC manufacturing facility, Christopher Wilkes joins as Vice President of Production & Supply Chain and Nichole Coggins joins as Director, Quality Engineering. Based at the company’s Manassas, VA R&D lab, Maggie Engert joins as Biomaterials Scientist. Read more about Christopher, Nichole and Maggie (https://i2pure.com/PR-I2Pure-Staff-Expansion-Bios.shtml).
By I2Pure Corp. · Via Business Wire · October 5, 2026
Forbes Recognizes Fifth Third for Customer Service Excellence for Fourth Year
Fifth Third Bancorp (NYSE: FITB) has been named to the 2027 Forbes Best Customer Service list, marking the fourth consecutive year the Bank has earned a place on the annual ranking. The recognition reflects Fifth Third's ongoing commitment to delivering exceptional customer experiences through personalized service, innovative banking solutions and trusted financial guidance.
By Fifth Third Bancorp · Via Business Wire · October 5, 2026
XTEND AI Robotics, Inc. Secures U.S. Patent for Smart Payloads Capable of Actively Directing Missions
XTEND AI Robotics, Inc. (NYSE: XTND), a leader in software systems and Physical AI, today announced that the United States Patent and Trademark Office has granted U.S. Utility Patent No. 12,743,960, covering a system in which a smart payload can give XTEND's platform real-time instructions on how to navigate and behave in the field.
By XTEND AI Robotics, Inc. · Via Business Wire · October 5, 2026
Stellar Cyber 7.0 Makes the Agentic SOC Measurable, Actionable and Operational at Scale
Stellar Cyber, the AI-native security operations platform purpose-built for MSSPs and lean enterprise security teams, today announced Stellar Cyber 7.0, a milestone release that advances the Human-Augmented Autonomous SOC from a vision for applying AI to security operations into a practical operating model for running them.
By Stellar Cyber · Via Business Wire · October 5, 2026
Detroit Climbs into Terminix’s Top 10 as Fall Rodent Pressure Shifts Nationwide
Rodent activity is shifting across the country, with Detroit entering Terminix’s Top 10 for the first time, according to new data from Terminix®, a Rentokil Terminix company. Based on 2025 service data from more than 300 Rentokil-owned Terminix branches nationwide, where residents most frequently used rodent control services in 2025, the company’s annual list of the Top 50 Most Rodent-Infested Cities, reveals notable movement across the country. Five new cities entered the ranking, Milwaukee broke into the Top 20, and San Diego dropped 15 spots.
By Terminix · Via Business Wire · October 5, 2026
The Korea Fund, Inc. Appoints New Agent for its Discount Management Program
The Board of Directors (the “Board”) of The Korea Fund, Inc. (NYSE: KF) (the “Fund”) has appointed Canaccord Genuity LLC, (the “Program Manager”) to serve as its agent and broker for purposes of implementing the Fund’s Discount Management Program (the “Program”), with effect as of October 5, 2026.
By The Korea Fund, Inc. · Via Business Wire · October 5, 2026
Datavant and ID.me Partner to Make Patient Access to Medical Records Faster and More Secure
Datavant, the data collaboration platform trusted for healthcare, today announced the availability of a new identity verification integration with ID.me, the next-generation digital identity wallet simplifying how individuals securely prove their identity online. The integration with Datavant’s Patient Request Tool is designed to help patients request their medical records faster and more easily via secure, simple digital credentials.
By Datavant · Via Business Wire · October 5, 2026
Bojangles Transforms into Boojangles this Halloween with New Tricks and Treats to Enjoy
Bojangles is turning up the spooky this season, transforming once again into Boojangles, with restaurants embracing the Boojangles look through Halloween-themed restaurant wraps and in-store decor. And this year, the “Scarolina Legend” comes with something new to sink your teeth into: the Bite Box.
By Bojangles · Via Business Wire · October 5, 2026
Catalent Launches Accelerated Gene-to-Drug Substance Program for Complex Molecules in the U.S.
Catalent, Inc., the leading global contract development and manufacturing organization (CDMO) dedicated to helping people live better and healthier lives, today announced the U.S. launch of an accelerated gene-to-drug substance program for complex biologics, designed to help developers move bispecifics, multispecifics and other next-generation molecules from gene sequence to drug substance in 10 months. The program builds on Catalent's Rapid Antibody offering for traditional mAbs, which supports gene-to-GMP drug substance in as little as 8 months.
By Catalent, Inc. · Via Business Wire · October 5, 2026
Holiday Shoppers Turn to Gift Cards as Budgets Tighten
U.S. shoppers are turning to gift cards to keep holiday gifting within budget, while using loyalty points and promotions to make their available spending power go further. At the same time, AI is beginning to influence where that spending goes, according to new research from Blackhawk Network (BHN), a global branded payments provider.
By Blackhawk Network · Via Business Wire · October 5, 2026
Epicrispr Reports Positive Six-Month Data at The World Muscle Society Meeting Demonstrating Increased Lean Muscle Volume and Muscle Strength in FSHD Patients Treated with EPI-321
Epicrispr Biotechnologies, a clinical-stage company pioneering epigenetic therapies, today announced updated six-month clinical data from the ongoing open-label, first-in-human Phase 1/2 study evaluating EPI-321 in patients with facioscapulohumeral muscular dystrophy (FSHD). This updated data from the first six patients enrolled in the study were presented at the 31st Annual Congress of the World Muscle Society (WMS 2026) in Hiroshima, Japan.
By Epicrispr Biotechnologies · Via Business Wire · October 5, 2026
Hans Vestberg Joins Evercore as Senior Advisor
Evercore announced today that Hans Vestberg has joined the firm as a senior advisor, based in New York.
By Evercore · Via Business Wire · October 5, 2026
Wells Fargo to Announce Third Quarter 2026 Earnings on Oct. 13, 2026
Wells Fargo & Company (NYSE: WFC), as previously announced, will report its third quarter 2026 earnings results on Tuesday, Oct. 13, 2026, at approximately 7:00 a.m. Eastern time. The results will be available online on our Investor Relations webpage. In addition to being available on the company’s Investor Relations website, the earnings results also will be available on the Securities and Exchange Commission website.
By Wells Fargo & Company · Via Business Wire · October 5, 2026
Ryan Establishes Presence in Brazil With Acquisition of Tax Technology Firm Comtax
Ryan, a leading global tax services and software provider, is pleased to announce the acquisition of Comtax, a São Paulo-based tax technology and consulting firm specializing in tax determination, tax compliance, and technology-enabled tax operations. The acquisition establishes Ryan’s presence in Brazil and expands the Firm’s ability to help clients manage the country’s demanding tax, compliance, and technology requirements with enhanced accuracy, control, and efficiency.
By Ryan · Via Business Wire · October 5, 2026
Northern Trust Wealth Management Continues Northeast Region Expansion with Two Senior Appointments
Northern Trust Wealth Management has appointed Beth Emswiler and Andrew Borner as Senior Managing Directors in the Northeast Region. Emswiler is based in New York, while Borner is based in Greenwich, Connecticut, strengthening the firm’s investment capabilities and client leadership in both markets.
By Northern Trust · Via Business Wire · October 5, 2026
Jamie Showers Joins Edgar Matthews & Co. as Managing Director and Head of Syndicate & Sales
Edgar Matthews & Co. LLC ("Edgar Matthews"), a leading independent investment bank focused on the structured finance ecosystem, today announced that Jamie Showers has joined the firm as a Managing Director and Head of Syndicate & Sales. Mr. Showers will lead Edgar Matthews’ structured products syndicate and institutional investor coverage efforts, with a particular focus on insurance companies and other institutional investors across private structured credit and asset-based finance.
By Edgar Matthews & Co. LLC · Via Business Wire · October 5, 2026
Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing
ORION CORPORATION PRESS RELEASE 05 OCTOBER 2026 at 8:00am ET
By Orion Oyj · Via GlobeNewswire · October 5, 2026
Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom
– Expands patient access to opioid-sparing pain control and advances 5x30 strategy – 
By Pacira BioSciences · Via GlobeNewswire · October 5, 2026
Zscaler Collaborates with IBM and Red Hat to Protect Private Applications from Frontier AI-Powered Threats
New collaboration combines Zscaler Autonomous Application Shield with Lightwell from IBM and Red Hat to help organizations reduce exposure between vulnerability disclosure and patch deployment through inline protection and validated remediation
By Zscaler, Inc. · Via GlobeNewswire · October 5, 2026
TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement
MALVERN, Pa., Oct. 05, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio” or the “Company”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the Company's Liora Monofilament Scaffold (“Liora”) product.
By TELA Bio, Inc. · Via GlobeNewswire · October 5, 2026
Magnite to Announce Third Quarter 2026 Financial Results on November 4, 2026
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, will announce its financial results for the third quarter ended September 30, 2026 after the market close on Wednesday, November 4, 2026. The Company will host a conference call at 1:30 PM (PT) / 4:30 PM (ET) the same day to discuss its financial results and outlook.
By Magnite, Inc. · Via GlobeNewswire · October 5, 2026
Kratos Secures More Than $100 Million in Contracts for Space and Cyber Mission Capabilities
SAN DIEGO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in defense, national security, and global markets, today announced multiple contract awards totaling over $100 million to develop prototype mission applications and cyber capabilities providing space intelligence data in support of joint operations across the space and cyberspace domains.
Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins
Multi-year expansion of the companies’ 2025 agreement to use Gate’s Molecular Gate drug discovery engine to design molecular gate medicines for Lilly targets
By Gate Bioscience · Via GlobeNewswire · October 5, 2026
Trasteel Holding S.A., Through Newly Established Trasteel Magona, Takes Over Operations of La Magona d’Italia Steel Plant in Piombino, Italy
Lease of the Liberty Magona business unit is now effective, opening a new phase for one of Italy’s historic producers of cold-rolled, galvanized and pre-painted steel
By Sizzle Acquisition Corp. II · Via GlobeNewswire · October 5, 2026
Angeion Group Names Lenny Izzo as Managing Director, Corporate Bankruptcy
Veteran legal services executive to lead Angeion Group’s Corporate Bankruptcy Services and accelerate growth in corporate restructuring administration
By Angeion Group · Via GlobeNewswire · October 5, 2026
MAPS and International Alliance of Psychedelic Therapy Practitioners Announce Partnership to Advance Training for Psychedelic-Assisted Therapy
WASHINGTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) announced a new strategic partnership with the International Alliance of Psychedelic Therapy Practitioners (Psychedelic Therapy Alliance), a professional association formed in 2023 for practitioners offering psychedelic-assisted therapy in legal settings.
MindWave Innovations Signs Agreement with US-Based BlockAssure to Build and Operate AssureChain, an End-to-End Insurance and Reinsurance Network
AssureChain, a dedicated subnet of MindChain, will run every insurance function on-chain, while MindChain provides settlement and anchoring to Ethereum
By MindWave Innovations Inc. · Via GlobeNewswire · October 5, 2026
Osisko Gold Intersects 7.28 g/t Au over 16.15 m (105 m Vertical Depth), including 173.66 g/t Au over 0.60 m, and 7.13 g/t Au over 11.60 m (61 m Vertical Depth) in Lowhee Zone Underground Infill Drilling at Cariboo Gold Project
By Osisko Gold Group Inc. · Via GlobeNewswire · October 5, 2026
PLDT Wins Silver Award at 2026 UiPath AI Breakthrough Awards for Agentic AI-Driven Enterprise Transformation
UiPath (NYSE: PATH), a leader in business orchestration and automation, today announced that PLDT, the leading digital services provider in the Philippines, is using a fleet of in-house AI agents built with UiPath Agent Builder™, Integration Service, and Robots to reclaim tens of thousands of hours of manual work annually. Powered by the UiPath Platform™, these agents are deployed across enterprise sales, risk management, and lead generation to eliminate bottlenecks and empower PLDT's workforce.
By UiPath · Via Business Wire · October 5, 2026
Syntec Optics (Nasdaq: OPTX) Lands Artemis III Production Orders, Expands Space Portfolio to Moon Missions
ROCHESTER, NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec Optics” or the “Company”), a leading provider of deep-tech products to defense, space, and AI data centers, today announced recurring production orders for actuators in NASA's Artemis III rockets. 
By Syntec Optics · Via GlobeNewswire · October 5, 2026
Toshiba Accelerates the Human Element in AI Workflows
Toshiba America Business Solutions is accelerating approval and decision processes for growing companies and global brands with the introduction of its Elevate Sky® Workflow UserConnect module.
By Toshiba · Via Business Wire · October 5, 2026
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly
Trial follows promising MAR002 Phase 1 clinical trial results that demonstrated deep and durable IGF-1 suppression with PK properties that may enable dosing as infrequently as once every two weeks, compared to the daily subcutaneous injections required by the current standard of care
By Lisata Therapeutics, Inc. · Via GlobeNewswire · October 5, 2026
STMicroelectronics announces status of common share repurchase program
STMicroelectronics announces status of common share repurchase program
Coveron completes SOC 2 Type II certification with zero exceptions
LONDON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Coveron, an identity theft and scam protection service developed by Nord Security, is proud to announce that it has successfully completed SOC 2 Type II certification. Coveron concluded the audit with zero exceptions and recommendations, underlining the brand's commitment to protecting its customers' data.
By Coveron · Via GlobeNewswire · October 5, 2026
Forward Therapeutics Announces Positive Phase 1 Data for Potential Best-in-Class Oral TNFR1 Signaling Inhibitor FT2109, Supporting Advancement into Phase 2 Development
BOSTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Forward Therapeutics, Inc. (“Forward” or the “Company”), a clinical-stage biotechnology company developing oral small molecule therapies for inflammation-driven diseases, today announced positive Phase 1 clinical and preclinical data for FT2109, its novel, potential best-in-class oral selective TNFR1 signaling inhibitor. The data are included in two abstracts accepted for presentation at the American College of Rheumatology (ACR) Convergence 2026, taking place November 6–11 in Orlando, Florida.
By Forward Therapeutics · Via GlobeNewswire · October 5, 2026
Altus Achieves Leading AI Governance Certification, Setting New Standard for Responsible AI in Commercial Real Estate
Global ISO/IEC 42001 certification underscores Altus’ commitment to delivering trusted, transparent and secure AI solutions for the CRE industry
By Altus Group Limited · Via GlobeNewswire · October 5, 2026
Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease
-- Global, first-in-human study underway designed to evaluate safety, tolerability, and initial clinical efficacy of PM577a --
By Prime Medicine, Inc. · Via GlobeNewswire · October 5, 2026
4DMT to Host Investor Day on October 21, 2026
EMERYVILLE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that the Company will host an Investor Day on Wednesday, October 21, 2026, in New York City. The live event will begin at 10:30am ET and include a Company presentation, KOL panel discussions and a live Q&A session.
By 4D Molecular Therapeutics, Inc. · Via GlobeNewswire · October 5, 2026
DFDV Preliminary Q3’26 Estimates Indicate Double-Digit SPS Growth and More Than 100% NAV Per Share Growth In Q3; SOL Treasury Growth Rises to 11% Since August 12
Continued purchases and organic accumulation drive approximately 11% growth in SOL holdings since the Company’s August 12 Earnings Update
By DeFi Development Corporation · Via GlobeNewswire · October 5, 2026
Mastercard Selects Rezolve Ai in Worldwide Reseller Agreement to Advance AI-Powered Commerce
Mastercard to lead customer sales engagement under worldwide agreement, expanding Rezolve Ai’s distribution and subscription revenue opportunity
By Rezolve AI PLC · Via GlobeNewswire · October 5, 2026